, Tracking Stock Market Picks
Enter Symbol:
Keryx Biopharmaceuticals, Inc. (KERX) [hlAlert]

down 16.55 %

Keryx Biopharmaceuticals, Inc. (KERX) rated Buy with price target $13 by Stifel Nicolaus

Posted on: Tuesday,  Jan 29, 2013  8:25 AM ET by Stifel Nicolaus

Stifel Nicolaus rated Buy Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) on 01/29/2013, when the stock price was $7.43. Since
then, Keryx Biopharmaceuticals, Inc. has lost 16.55% as of 01/12/2016's recent price of $6.20.
If you would have followed this Stifel Nicolaus's recommendation on KERX, you would have lost 16.55% of your investment in 1078 days.

Keryx Biophamaceutical, Inc. uses data discovered through the mapping of the human genome to generate drug candidates that target the regulation of protein kinases. Protein kinases play a key role in the way cells communicate.

Stifel Nicolaus research focuses on all market caps, but is a leader in small- and mid-cap research. The department is staffed predominately with industry professionals from outside Wall Street. In fact, approximately 50% of its analysts have hands-on work experience in the industry that they research. Stifel Nicolaus believes industry experience, its opportunistic approach, and broad market cap coverage drive excess returns and its award-winning franchise.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/29/2013 8:25 AM Buy
7.43 13.00
as of 12/13/2013
1 Week down  -4.54 %
1 Month down  -4.09 %
3 Months up  33.58 %
1 YTD up  63.79 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy